Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors
- PMID: 38473402
- PMCID: PMC10931077
- DOI: 10.3390/cancers16051045
Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors
Abstract
This study aims to review the status of the clinical use of monoclonal antibodies (mAbs) that have completed or are in ongoing clinical trials for targeted fluorescence-guided surgery (T-FGS) for the intraoperative identification of the tumor margins of extra-hematological solid tumors. For each of them, the targeted antigen, the mAb generic/commercial name and format, and clinical indications are presented, together with utility, doses, and the timing of administration. Based on the current scientific evidence in humans, the top three mAbs that could be prepared in a GMP-compliant bank ready to be delivered for surgical purposes are proposed to speed up the translation to the operating room and produce a few readily available "off-the-shelf" injectable fluorescent probes for safer and more effective solid tumor resection.
Keywords: fluorophores; monoclonal antibodies; solid malignancies; surgical oncology; targeted fluorescence-guided surgery.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Fluorescence-Guided Surgery: A Review on Timing and Use in Brain Tumor Surgery.Front Neurol. 2021 Jun 16;12:682151. doi: 10.3389/fneur.2021.682151. eCollection 2021. Front Neurol. 2021. PMID: 34220688 Free PMC article. Review.
-
Identification of Pediatric Tumors Intraoperatively Using Indocyanine Green (ICG).Ann Surg Oncol. 2023 Nov;30(12):7789-7798. doi: 10.1245/s10434-023-13953-y. Epub 2023 Aug 5. Ann Surg Oncol. 2023. PMID: 37543553 Review.
-
Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents.Front Oncol. 2021 Jun 30;11:674083. doi: 10.3389/fonc.2021.674083. eCollection 2021. Front Oncol. 2021. PMID: 34277418 Free PMC article. Review.
-
Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.Mol Imaging Biol. 2023 Feb;25(1):122-132. doi: 10.1007/s11307-021-01657-2. Epub 2021 Oct 12. Mol Imaging Biol. 2023. PMID: 34642899 Free PMC article.
-
Fluorescence-Guided Surgery.Front Oncol. 2017 Dec 22;7:314. doi: 10.3389/fonc.2017.00314. eCollection 2017. Front Oncol. 2017. PMID: 29312886 Free PMC article. Review.
Cited by
-
Advancing Neuroblastoma Surgery through the Clinical Integration of Virtual Reality and Indocyanine Green Fluorescence-Guided Imaging: A Case Report.European J Pediatr Surg Rep. 2025 Jul 24;13(1):e23-e30. doi: 10.1055/a-2646-8880. eCollection 2025 Jan. European J Pediatr Surg Rep. 2025. PMID: 40727089 Free PMC article.
-
Monoclonal antibodies: From magic bullet to precision weapon.Mol Biomed. 2024 Oct 11;5(1):47. doi: 10.1186/s43556-024-00210-1. Mol Biomed. 2024. PMID: 39390211 Free PMC article. Review.
-
Accurate Co-Localization of Luciferase Expression and Fluorescent Anti-CEA Antibody Targeting of Liver Metastases in an Orthotopic Mouse Model of Colon Cancer.Cancers (Basel). 2024 Sep 29;16(19):3341. doi: 10.3390/cancers16193341. Cancers (Basel). 2024. PMID: 39409961 Free PMC article.
-
Optical imaging guidance in oncologic surgery and interventional oncology.Pharmacol Res. 2025 Feb;212:107612. doi: 10.1016/j.phrs.2025.107612. Epub 2025 Jan 17. Pharmacol Res. 2025. PMID: 39826822 Free PMC article. Review.